(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…
Football success did not drive decisions, says Spurs chief
Football success did not drive decisions, says Spurs chief Source: www.channelnewsasia.com






